-
-
Call more information
660-596-2224 -
Author: Lalitha Sundararaman, MD, FASA ASA Monitor December 2024, Vol. 88, 33–34. Figure: Dosing considerations in the patients with obesity. Obesity has risen to new heights and encompasses 23% of the world’s population. Obesity in adolescents has increased four-fold over the last two decades. The use of GLP-1 receptor agonists has grown exponentially. In addition, there […]
Read MoreAuthors: Shahla Siddiqui, MBBS, MSc, FCCM et al ASA Monitor December 2024, Vol. 88, 1–5. The conflict between an individual physician’s duty to treat versus their personal issues of conscience and moral integrity has become more complex in recent years (Clinical Ethics: A Practical Approach to Ethical Decisions in Clinical Medicine. 8th edition, 2015). The loss of […]
Read MoreASA Monitor December 2024, Vol. 88, 28–29. FDA approves Exact Sciences’ Cologuard Plus test Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, today announced the U.S. Food and Drug Administration (FDA) approved the Cologuard Plus™ test, the company’s next generation multitarget stool DNA test. The Cologuard Plus test is now approved for […]
Read MoreAuthor: Robin Hocevar ASA Monitor December 2024, Vol. 88, 32. One surefire way to start a lively conversation among anesthesiologists is to bring up the ideal timeline children should fast before surgery. This clinical controversy was the focus of a point-counterpoint discussion at ANESTHESIOLOGY® 2024. Joelle Karlik, MD, Pediatric Anesthesia and Pain Medicine, Children’s Healthcare of Atlanta-Arthur […]
Read MoreASA Monitor December 2024, Vol. 88, 25. Medical malpractice statistics are sobering. One in three providers will be sued over the course of their career (StatPearls. 2024). The annual overall rate of paid malpractice claims among all specialties is 14.1 per 1,000 physician-years (JAMA Intern Med 2017;177:710-8). Anesthesiologists experience an annual rate of paid malpractice claims of […]
Read More